Vontobel Holding’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460M | Buy |
4,286,905
+16,739
| +0.4% | +$1.8M | 1.47% | 19 |
|
|
2025
Q1 | $431M | Sell |
4,270,166
-1,348,304
| -24% | -$136M | 1.57% | 18 |
|
|
2024
Q4 | $502M | Sell |
5,618,470
-224,019
| -4% | -$20M | 1.72% | 15 |
|
|
2024
Q3 | $490M | Sell |
5,842,489
-2,527,469
| -30% | -$212M | 1.58% | 16 |
|
|
2024
Q2 | $645M | Buy |
8,369,958
+7,765,306
| +1,284% | +$598M | 2.09% | 11 |
|
|
2024
Q1 | $41.4M | Buy |
604,652
+71,889
| +13% | +$4.92M | 0.33% | 82 |
|
|
2023
Q4 | $30.8M | Buy |
532,763
+15,476
| +3% | +$895K | 0.26% | 98 |
|
|
2023
Q3 | $27.3M | Buy |
517,287
+44,427
| +9% | +$2.35M | 0.25% | 102 |
|
|
2023
Q2 | $25.6M | Sell |
472,860
-59,590
| -11% | -$3.22M | 0.22% | 110 |
|
|
2023
Q1 | $26.6M | Sell |
532,450
-69,316
| -12% | -$3.47M | 0.25% | 105 |
|
|
2022
Q4 | $27.5M | Buy |
601,766
+7,636
| +1% | +$350K | 0.28% | 97 |
|
|
2022
Q3 | $23.4M | Buy |
594,130
+19,778
| +3% | +$778K | 0.27% | 94 |
|
|
2022
Q2 | $21.7M | Buy |
574,352
+45,518
| +9% | +$1.72M | 0.23% | 106 |
|
|
2022
Q1 | $23.6M | Sell |
528,834
-27,882
| -5% | -$1.25M | 0.2% | 108 |
|
|
2021
Q4 | $23.9M | Buy |
556,716
+53,470
| +11% | +$2.3M | 0.2% | 112 |
|
|
2021
Q3 | $21.8M | Sell |
503,246
-9,440
| -2% | -$410K | 0.19% | 109 |
|
|
2021
Q2 | $22.2M | Sell |
512,686
-77,576
| -13% | -$3.35M | 0.19% | 106 |
|
|
2021
Q1 | $22.8M | Buy |
590,262
+10,072
| +2% | +$389K | 0.17% | 92 |
|
|
2020
Q4 | $23M | Buy |
+580,190
| New | +$23M | 0.15% | 92 |
|